Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hazumi is a traditional Unani herbo-mineral formulation manufactured by Dawakhana Tibbiya College (AMU) for the management of digestive troubles. It is indicated for improving digestion, increasing appetite, and relieving symptoms such as bloating, gas, indigestion, and acute gastric pain. The formulation is designed to support the harmonious and healthy functioning of the stomach, liver, intestines, and other allied digestive organs. According to the National Formulary of Unani Medicine, Hazumi contains a combination of herbal and mineral ingredients, including Jauhar-e-Gandhak (purified sulphur), Naushadar (ammonium chloride), Namak Siyah (black salt), Namak-e-Toam (common salt), Baobarang (Embelia ribes), Tukhm-e-Karafs (celery seeds), Filfil Siyah (black pepper), and Kaf-e-Dariya (cuttlefish bone).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hazumi.